Intervention Protocol

Therapeutic interventions for daytime somnolence in Parkinson's disease

  1. Joaquim Ferreira1,*,
  2. Tiago Mestre2,
  3. Russell M Hewett2,
  4. Miguel M Coelho1,
  5. Mário Rosa2,
  6. Olivier Rascol3,
  7. Cristina Sampaio1

Editorial Group: Cochrane Movement Disorders Group

Published Online: 17 OCT 2007

DOI: 10.1002/14651858.CD006808


How to Cite

Ferreira J, Mestre T, Hewett RM, Coelho MM, Rosa M, Rascol O, Sampaio C. Therapeutic interventions for daytime somnolence in Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006808. DOI: 10.1002/14651858.CD006808.

Author Information

  1. 1

    Faculdade de Medicina de Lisboa, Laboratório de Farmacologia Clínica e Terapêutica, Lisboa, Portugal

  2. 2

    Institute of Molecular Medicine, Neurological Clinical Research Unit, Lisboa, Portugal

  3. 3

    Faculté de Médecine, Pharmacologie Clinique, Toulouse, France

*Joaquim Ferreira, Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Hospital de Santa Maria, Av. Prof. Egas Moniz, Lisboa, 1649-028, Portugal. movementdisord@fm.ul.pt.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Primary objective
* To evaluate the efficacy and safety of pharmacological interventions for the treatment of daytime somnolence in PD.
Secondary objectives:
* To address the spectrum of pharmacological strategies proposed for the treatment of daytime somnolence in PD.
* To address the methodological quality of trials on the treatment of daytime somnolence in PD.